Join
Live feed
·
PRReleasevia Quantisnow
Veradermics Incorporated logo

Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy

ByQuantisnow·Wall Street's wire, on your screen.
MANE· Veradermics Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MANE (Veradermics Incorporated) and more on Quantisnow.